Top Page
Anchorstone Holdings Limited
(1592)
Anchorstone Holdings Limited (1592) vs. iShares MSCI Hong Kong ETF (EWH)
Anchorstone Holdings Limited Business Overview & Revenue Model
Anchorstone Holdings Limited Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.75M | 58.51M | 77.20M | 130.39M | 91.94M | 170.35M |
| Gross Profit | 14.89M | 15.38M | 23.95M | 31.35M | 11.17M | 19.10M |
| EBITDA | -80.29M | -79.42M | -31.91M | -21.94M | -31.05M | -22.75M |
| Net Income | -86.57M | -86.37M | -40.45M | -32.34M | -46.75M | -34.10M |
Balance Sheet | ||||||
| Total Assets | 103.88M | 104.59M | 190.27M | 231.82M | 274.64M | 333.50M |
| Cash, Cash Equivalents and Short-Term Investments | 628.00K | 308.00K | 507.00K | 1.32M | 2.68M | 218.00K |
| Total Debt | 45.57M | 47.66M | 60.08M | 99.67M | 125.11M | 164.18M |
| Total Liabilities | 166.61M | 158.69M | 155.03M | 178.20M | 191.61M | 209.51M |
| Stockholders Equity | -62.73M | -54.10M | 35.24M | 53.62M | 83.02M | 123.99M |
Cash Flow | ||||||
| Free Cash Flow | -3.40M | 3.71M | 13.65M | 9.63M | -2.00M | -18.36M |
| Operating Cash Flow | -3.40M | 3.71M | 13.65M | 9.66M | 1.96M | -18.31M |
| Investing Cash Flow | 1.00K | 1.00K | 2.00K | -24.00K | 30.28M | 4.80M |
| Financing Cash Flow | 2.33M | -4.17M | -13.46M | -9.41M | -27.78M | 751.00K |
Anchorstone Holdings Limited Technical Analysis
Anchorstone Holdings Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$127.00M | 5.96 | 10.51% | ― | 14.65% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$130.45M | 1.92 | 11.61% | ― | 5.34% | 43.91% | |
53 Neutral | HK$192.82M | 59.38 | 0.62% | 2.34% | -48.30% | -75.98% | |
49 Neutral | HK$690.51M | -138.30 | -3.68% | ― | -0.28% | -469.70% | |
45 Neutral | HK$228.96M | -0.50 | -46.79% | ― | 0.26% | 69.65% | |
38 Underperform | HK$42.28M | -0.38 | ― | ― | 1.43% | -83.97% |
Anchorstone Holdings Limited Corporate Events
Anchorstone Holdings Limited has disclosed that a winding-up petition has been filed by Hang Chin Marble Engineering Limited against its indirectly wholly owned subsidiary, Pacific Marble and Granite Limited, alleging insolvency over an unpaid judgment debt of about HK$9 million arising from prior construction and arbitration proceedings. The petition is scheduled to be heard on 11 February 2026, and while the company is currently seeking legal advice, its board maintains that the disputed amount is not expected to have a material adverse impact on the group’s overall operations or financial position, though shareholders and potential investors are urged to exercise caution pending further updates.
The most recent analyst rating on (HK:1592) stock is a Sell with a HK$0.19 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited has announced a change of auditors, following the resignation of Rongcheng (Hong Kong) CPA Limited, which cited considerations such as professional risks, internal resources and audit fees in deciding not to continue its engagement. The board, upon the recommendation of the audit committee, has appointed Guangshen (Hong Kong) CPA Limited as the new auditor with effect from 29 December 2025, filling the casual vacancy until the next annual general meeting; the company emphasized that there are no other matters related to the change requiring shareholders’ attention, signaling an orderly transition in its audit oversight rather than a dispute-driven departure.
The most recent analyst rating on (HK:1592) stock is a Sell with a HK$0.19 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited has announced a clarification regarding the appointment of Prof. Jiang Zhihong as an Independent Non-Executive Director and a member of the audit committee. The company corrected a clerical error in the previous announcement, specifying that Prof. Jiang has been serving as an independent non-executive director of Shanghai Haohai Biological Technology Co., Ltd since May 2020. This appointment is expected to enhance the company’s governance and oversight capabilities.
The most recent analyst rating on (HK:1592) stock is a Hold with a HK$0.25 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited has announced the composition of its board of directors and their respective roles. The board consists of executive directors and independent non-executive directors, with specific members chairing the Audit, Remuneration, and Nomination Committees. This announcement provides clarity on the governance structure of the company, potentially impacting its strategic decision-making and stakeholder confidence.
The most recent analyst rating on (HK:1592) stock is a Hold with a HK$0.25 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited has announced the composition of its board of directors and the roles of each member. The board consists of executive directors, including Chairman Lui Yue Yun Gary, and independent non-executive directors. The company has also detailed the members of its three board committees: Audit, Remuneration, and Nomination. This announcement provides clarity on the governance structure of the company, potentially impacting its strategic decision-making and offering insights into its corporate governance practices.
The most recent analyst rating on (HK:1592) stock is a Hold with a HK$0.33 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited has announced the appointment of Prof. Jiang Zhihong as an independent non-executive director, effective from December 10, 2025. Prof. Jiang brings over 30 years of experience in natural product chemistry and Chinese medicine quality research, which could enhance the company’s strategic direction and industry positioning. His extensive academic and professional background, including his roles at Macau University of Science and Technology, is expected to provide valuable insights and leadership to the board.
The most recent analyst rating on (HK:1592) stock is a Hold with a HK$0.33 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited has successfully completed the placement of 48,259,000 new shares, representing approximately 16.67% of its enlarged share capital, at a price of HK$0.25 per share. The placement raised gross proceeds of approximately HK$12.06 million, with net proceeds estimated at HK$11.78 million. The funds will be allocated towards repaying bank loans, settling other debts, and general working capital. This strategic move is expected to strengthen the company’s financial position and support its operational needs.
The most recent analyst rating on (HK:1592) stock is a Hold with a HK$0.33 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited, along with its subsidiaries, has entered into a third supplemental placing agreement to extend the date for the completion of the placing of new shares under a general mandate. The new extended date is set for 5 December 2025, allowing more time for the fulfillment of conditions under the placing agreement. This extension indicates the company’s efforts to ensure the successful completion of the share placement, which may impact its financial strategy and market positioning.
The most recent analyst rating on (HK:1592) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited has entered into a second supplemental placing agreement to extend the deadline for the completion of a share placement under a general mandate. The new extended long stop date is now set for 17 November 2025, allowing more time for the fulfillment of conditions necessary for the placement’s completion. This extension indicates the company’s ongoing efforts to manage its capital structure and may impact shareholder and investor decisions regarding the company’s securities.
Anchorstone Holdings Limited has announced the results of its Extraordinary General Meeting (EGM) held on 22 October 2025, where a resolution for share consolidation was approved by an overwhelming majority of shareholders. The share consolidation will become effective on 24 October 2025, and trading of the consolidated shares will begin on the same day. This move is expected to streamline the company’s share structure and potentially enhance the marketability and trading liquidity of its shares.
Anchorstone Holdings Limited announced the resignation of Ms. Ching Wan Wah Kitty as an independent non-executive director, effective October 22, 2025, due to her pursuit of other business and personal commitments. This resignation leaves the company with only two independent non-executive directors, falling below the minimum required by the Hong Kong Stock Exchange’s listing rules, which may impact the company’s compliance and governance structure.
Anchorstone Holdings Limited has announced the composition of its board of directors, which includes both executive and independent non-executive directors. The company has also outlined the structure of its three board committees: the Audit Committee, Remuneration Committee, and Nomination Committee, detailing the roles of each board member within these committees.